By
WilD on
February 4, 2012
Welcome back to our diabetes advice column, Ask D’Mine, hosted by veteran type 1, diabetes author and community educator Wil Dubois.
We never know where your queries might take us! Today, Wil’s delving into blood diseases and chicken soup…
{Need help navigating life with diabetes? Email us at AskDMine@diabetesmine.com}
George from Wyoming, type 2, writes: I recently visited my doctor and she told me that I have get an immunization for hepatitis because I have…
Read more »
By
WilD on
January 28, 2012
{Need help navigating life with diabetes? Email us at AskDMine@diabetesmine.com}
Yup, you guessed it: it’s another edition of our new diabetes advice column, Ask D’Mine, hosted by veteran type 1, diabetes author and community educator Wil Dubois.
Alex from Canada, type 1, writes: I was diagnosed roughly 9 months ago. Since then, my insulin requirements have increased every now and then. Last week, I needed 16u of basal insulin in the morning, and from that…
Read more »
It’s not too often we have a new insulin making its way on the scene, so we were excited to hear that Novo Nordisk filed two applications with the FDA for a new “ultra long acting” insulin called Degludec, and another for something called DegludecPlus, a combination of degludec and insulin aspart (Novolog), which would be available in an insulin pen in a fixed 70% degludec/30% Novolog ratio. The company is hoping for FDA approval…
Read more »
There’s nothing quite like the horror of having an insulin pump suddenly go postal at eleven o’clock on a Saturday night. The buttons that don’t respond to touch, the motor that spins wildly, the shrieking alarms. It’s almost enough to induce a panic attack!
Although insulin pumps are the treatment method of choice for both Amy and I, they are machines. Which means that sometimes they go kaputt. Unlike Amy who rocks an Omnipod, I…
Read more »
Last week, the New York Chapter of the Juvenile Diabetes Research Foundation hosted their annual research briefing. Many chapters around the country host similar research briefings, and I was excited to find out that our local meeting would feature Dr. Sanjoy Dutta, Director of Glucose Control Therapies within the Treatment Therapies Program.
I want to note that although there’s been a lot of controversy surrounding the addition of treatment goals to JDRF’s mission, I whole-heatedly…
Read more »
